Kazia Therapeutics vs Silo Pharma
KZIA and SILO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How KZIA and SILO compare
Silo Pharma grew revenue faster over the last twelve months (−25.0% versus −98.2% for Kazia Therapeutics).
Silo Pharma keeps more of each dollar of sales as profit, with a net margin of −8270% compared with −49291% at Kazia Therapeutics.
Silo Pharma scores higher on the StockData Score (2 against 1 for Kazia Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | KZIA | SILO |
|---|---|---|
| Size and price | ||
| Market cap | – | $2.7M |
| Share price | $5.31 | $1.71 |
| Change, 1 year | −15.3% | −72.4% |
| Change, 5 years | −98.9% | −98.8% |
| Beta (5Y) | 4.08 | 2.90 |
| Employees | 14 | 3 |
| StockData Score | ||
| Total score | 1 | 2 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 50.2× |
| P/B | – | 0.6× |
| Growth | ||
| Revenue growth (TTM) | −98.2% | −25.0% (better) |
| Revenue growth, 5Y average | – | 12.0% |
| Profitability | ||
| Gross margin | – | −14.8% |
| Operating margin | – | −8250% |
| Net margin | −49291% | −8270% (better) |
| Return on equity | – | −91.2% |
| Financial health | ||
| Interest coverage | – | −112.0× |
| Current ratio | 2.87 | 5.36 (better) |
| Altman Z-score | – | −5.17 |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.45% | 9.0% |
| Held by insiders | 0.29% | 13.8% |
| Insider net buying, 12 months | – | $2.1K |
| Superinvestors holding | 1 | – |
| Short interest, % of float | – | 1.0% |
Go deeper
- KZIA stock overview
- KZIA income statement
- KZIA valuation and score
- SILO stock overview
- SILO income statement
- SILO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.